Immupharma Regulatory News (IMM)

6 Aug 2007 14:40

Immupharma PLC06 August 2007 For Immediate Release 6 August 2007 Grant of Options ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drugdiscovery and development company, announces the granting of share options toits Directors. The Company has adopted a HM Revenue & Customs approved shareownership plan (CSOP) and an unapproved share option scheme. The amount of options granted are summarised in the following table: Director Options Granted Richard Warr 140,000Robert Zimmer 150,000Dimitri Dimitriou 140,000Franco di Muzio 100,000Ajay Agrawal 100,000 The option price was set at 76.8p per share. The options are exercisable after 3years and up to 10 years from being granted. For further information, please contact: ImmuPharma PLCDimitri Dimitriou, Chief Executive Officer + 44 020 7152 4080Richard Warr, ChairmanDr Robert Zimmer, President & Chief Scientific Officer +33 389 32 76 50 Buchanan Communications +44 20 7466 5000Lisa BaderoonRebecca Skye Dietrich Teather & Greenwood (NOMAD & Broker) +44 020 7426 9000Thilo HoffmannJeff Keating This information is provided by RNS The company news service from the London Stock Exchange